BCI
DRNA

Brinker Capital Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Brinker Capital Investments’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,131
Closed -$223K – 1301
2020
Q4 		$223K Buy
+10,131
New +$223K ﹤0.01% 973